Renal Cell Carcinoma (RCC)

Renal cell carcinoma (RCC), also called hypernephroma, renal adenocarcinoma or renal or kidney cancer, is the most common kind of kidney cancer found in adults. Kidneys have the function of taking out waste products from the body and produce urine. In this type of cancer, the malignant cells are found in the lining of tubules (very small tubes) in the kidney.

Showing 1–12 of 31 results

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
1
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
PD-L1
Monoclonal Antibody
Bavencio®
20 mg/mL
2 mg
-80°C
2021.01
143,00 
view product
Max: 10
Min: 3
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2018.06
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2018.09
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2018.09
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2018.12
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2019.03
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2019.08
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
2 mg
-80°C
2019.10
212,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
yes
2 mg
-80°C
2021.03
212,00 
view product
Max: 6
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
3 mg
-80°C
2017.09
267,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
3 mg
-80°C
2018.03
267,00 
view product
Max: 10
Min: 2
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
12.5 mg
-80°C
2024.06
367,00 
view product
Max: 10
Min: 1
Step: 1
VEGF-A
Monoclonal Antibody
Avastin®
25 mg/mL
yes
2 mg
-80°C
2024.07
212,00 
view product
Max: 10
Min: 2
Step: 1
CTLA-4
Monoclonal Antibody
Yervoy®
5 mg/mL
yes
2 mg
-80°C
2024.09
874,00 
view product
Max: 10
Min: 1
Step: 1
CTLA-4
Monoclonal Antibody
Yervoy®
5 mg/mL
yes
2 mg
-80°C
2021.08
874,00 
view product
Max: 2
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2024.08
307,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2025.05
316,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2025.03
316,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2018.08
316,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2018.10
316,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2018.02
316,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2019.05
316,00 
view product
Max: 7
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2019.01
316,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2020.09
316,00 
view product
Max: 7
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2020.11
316,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Opdivo®
10 mg/mL
2 mg
-80°C
2021.02
316,00 
view product
Max: 2
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
2018.07
528,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
2018.12
528,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
2019.03
528,00 
view product
Max: 10
Min: 1
Step: 1
PD-1
Monoclonal Antibody
Keytruda®
25 mg/mL
2 mg
-80°C
2019.07
528,00 
view product
Max: 10
Min: 1
Step: 1
1 2

Not looking for Renal Cell Carcinoma (RCC)?

Search our therapeutic molecules product database